Patents Assigned to Fratagene Therapeutics S.R.L.
  • Compositions and methods for treating Friedreich's ataxia
    Patent number: 10442779
    Abstract: The invention provides compositions and methods useful for the treatment of Friedreich's ataxia. In some embodiments, the invention provides compositions and methods useful for inhibiting the ubiquitination of frataxin.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: October 15, 2019
    Assignee: FRATAGENE THERAPEUTICS S.R.L.
    Inventors: Roberto Testi, Ottaviano Incani, Alessandra Rufini, Gabriella DeMartino
  • Frataxin mutants
    Patent number: 9944906
    Abstract: Described herein are compositions and methods for treating Friedreich's Ataxia (FRDA). In some aspects, mutant forms of frataxin which are resistant to ubiquitination are provided. In some aspects, pharmaceutical compositions comprising mutant frataxin are provided. In further aspects, methods of using mutant frataxin are provided.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: April 17, 2018
    Assignee: FRATAGENE THERAPEUTICS S.R.L.
    Inventor: Roberto Testi
  • METHODS OF TREATING FRIEDREICH'S ATAXIA USING SRC INHIBITORS
    Publication number: 20170296540
    Abstract: In one aspect, the invention presents a method of treating Friedreich's ataxia (FRDA) by administering a therapeutically effective amount of an Src inhibitor.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 19, 2017
    Applicant: Fratagene Therapeutics S.R.L.
    Inventors: Roberto Testi, Florence Malisan